RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
about
Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesisNovel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice.Clinicopathological significance and potential drug target of RUNX3 in breast cancer.RUNX3 Controls a Metastatic Switch in Pancreatic Ductal AdenocarcinomaRUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.RUNX3 is down-regulated in glioma by Myc-regulated miR-4295The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis.Apoptotic cell death in neuroblastoma.MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain.p53: the attractive tumor suppressor in the cancer research field.RUNX family: Regulation and diversification of roles through interacting proteins.RUNX Family Participates in the Regulation of p53-Dependent DNA Damage Response.Role of p53 in Cell Death and Human Cancers.The RUNX family: developmental regulators in cancer.Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation.Toxoplasma gondii Rhoptry Protein ROP16 Mediates Partially SH-SY5Y Cells Apoptosis and Cell Cycle Arrest by Directing Ser15/37 Phosphorylation of p53Molecular mechanism underlying the antiproliferative effect of suppressor of cytokine signaling-1 in non-small-cell lung cancer cells.RUNX3 interacts with MYCN and facilitates protein degradation in neuroblastoma.Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.UnPAKing RUNX3 functions-Both sides of the coin.Genome profiling of pancreatic adenocarcinoma.RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer.Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.RUNX3 regulates CDKN1A transcriptionTruncated forms of RUNX3 Unlike Full Length Protein Alter Cell Proliferation in a TGF-β Context Dependent Manner.A cautionary tale of sense-antisense gene pairs: independent regulation despite inverse correlation of expression.Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants.RUNX3 binds TP53Roles of RUNX in Solid Tumors.A Regulatory Role for RUNX1, RUNX3 in the Maintenance of Genomic Integrity.Runx3 and Cell Fate Decisions in Pancreas Cancer.RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.Of mice and men: the nonrandom genomic instability in hepatocarcinogenesis.
P2860
Q26775839-FD7BE77D-4726-45BE-9A26-563A457617EEQ26777988-8BA85CDC-9786-4292-ABAD-7CC658C4369EQ33837122-691C966F-1E47-4FE0-9F10-481150F286C4Q34700919-37CD4D8E-FDF6-4015-9E45-10C364850785Q35690596-DFF500A0-DF5E-4B69-9E98-5DBA2586DC0CQ36259257-2D4441E1-105A-4F10-AB44-55E6C4B0C632Q36595241-67986FE0-DDC3-4E05-84B8-2319D0A14DCDQ37226515-85219154-8C1A-443D-AC78-E841BF87B0E4Q37679253-B398F671-9157-4D72-8726-3645A622EF7BQ37726121-A5A40040-DC0A-4CBE-A9F3-DDEB95D1970AQ37824262-4C47044A-6A88-4F93-904F-42FC6E69D1C2Q38062515-CBAD2F91-4850-42DE-A984-2E8F48FECCCDQ38147113-0B841977-8543-4635-83A4-A5112E0D70A2Q38161342-78C7B17E-05F8-4C57-AC90-4CE6A760AF21Q38319972-98D33EA4-CABE-402B-B02D-9864C59212DBQ38320046-83FE4329-63D1-4CD1-B55B-2CA5CD124336Q38838992-B34F6DA5-E414-42B5-ACD5-13FCCC62B944Q39107722-603C055B-FE71-4B1E-9577-43A8B4B88774Q39126205-C1813B4F-B0AD-4853-BCA7-60DE079C3D04Q39160361-85F7FD7C-FB8F-462B-8E5C-4CB87D95E87DQ39382872-0D394163-6848-40B5-99EA-4C57E6221719Q39574924-B7C0F480-B01C-42E1-9965-A6822F9573D0Q40545042-B3EF84A3-9934-4261-9BDF-698FF3567549Q44456898-349736E7-86C6-485E-BE32-372913D9D1B8Q45316830-256590B0-65F8-4328-AA03-16C1E562F6D6Q45373142-E8EF759A-CA17-48F3-9F45-55922D43904AQ47094223-37D31BA1-C708-4C0D-BBCA-ADE831CC70E8Q47552260-8CBB03C8-0288-4786-BE93-C1BA27B3E609Q50290741-1B15514E-AC1C-449F-9087-43A2A240A069Q50796410-73E38B57-ABB9-4B59-9920-421038C21290Q51097592-B9E91D11-0534-48B9-8C45-5E615BB07001Q51097608-D9105AD1-B914-4C36-9BA6-1F8BA3FDBFCBQ51097612-09C2DBE3-71F6-44AE-9F59-D26AED4B9CAAQ52646480-41AABA8F-D258-4281-8CAE-FCC6E691E397Q53289507-5C3DAD1B-AFB6-4F69-A11C-24D10ABEBF33
P2860
RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@ast
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@en
type
label
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@ast
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@en
prefLabel
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@ast
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@en
P2093
P2860
P356
P1476
RUNX3 modulates DNA damage-med ...... cts as a co-activator for p53.
@en
P2093
Akira Nakagawara
Chizu Yamada
Hajime Kageyama
Hideki Kimura
Ken-ichi Inoue
Kiyohiro Ando
Masaru Miyazaki
Rintaro Okoshi
Toshinori Ozaki
Yoshiaki Ito
P2860
P304
16693-16703
P356
10.1074/JBC.M109.055525
P407
P577
2010-03-30T00:00:00Z